Medicover Dividends and Buybacks
Dividend criteria checks 0/6
Medicover is a dividend paying company with a current yield of 0.72%.
Key information
0.7%
Dividend yield
0%
Buyback Yield
| Total Shareholder Yield | 0.7% |
| Future Dividend Yield | 1.2% |
| Dividend Growth | 35.6% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | SEK 0.120 |
| Payout ratio | 91% |
Recent dividend and buyback updates
Recent updates
Medicover AB (publ)'s (STO:MCOV B) Popularity With Investors Is Clear
Dec 12
The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business
Nov 07Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return
Oct 24Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects
Apr 22Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings
Apr 04Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet
Mar 05Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price
Feb 11Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture
Dec 20Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?
Dec 02Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business
Sep 12Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet
Aug 21Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?
Jun 12Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends
May 27Is Medicover (STO:MCOV B) Using Too Much Debt?
May 12Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes
Feb 16Is Medicover (STO:MCOV B) Using Too Much Debt?
Jan 30Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?
Dec 30Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)
Dec 17Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger
Oct 30Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?
Oct 16Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now?
Sep 09Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B)
Jul 25Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet
Jul 12Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B)
Jun 13At kr179, Is It Time To Put Medicover AB (publ) (STO:MCOV B) On Your Watch List?
May 29Stability and Growth of Payments
Fetching dividends data
Stable Dividend: MCOV B is not paying a notable dividend for the Swedish market, therefore no need to check if payments are stable.
Growing Dividend: MCOV B is not paying a notable dividend for the Swedish market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| Medicover Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (MCOV B) | 0.7% |
| Market Bottom 25% (SE) | 1.6% |
| Market Top 25% (SE) | 4.8% |
| Industry Average (Healthcare) | 1.2% |
| Analyst forecast (MCOV B) (up to 3 years) | 1.2% |
Notable Dividend: MCOV B's dividend (0.72%) isn’t notable compared to the bottom 25% of dividend payers in the Swedish market (1.59%).
High Dividend: MCOV B's dividend (0.72%) is low compared to the top 25% of dividend payers in the Swedish market (4.8%).
Earnings Payout to Shareholders
Earnings Coverage: MCOV B is not paying a notable dividend for the Swedish market.
Cash Payout to Shareholders
Cash Flow Coverage: MCOV B is not paying a notable dividend for the Swedish market.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 11:44 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medicover AB (publ) is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |
| Lars Hevreng | Danske Bank |
| James Alexander Vane-Tempest | Jefferies LLC |